loadpatents
name:-0.049688100814819
name:-0.048732042312622
name:-0.060788869857788
Liu; Cuixian Patent Filings

Liu; Cuixian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Cuixian.The latest application filed is for "methods using hdac11 inhibitors".

Company Profile
67.53.65
  • Liu; Cuixian - Madison CT
  • LIU; Cuixian - Boston MA
  • Liu; Cuixian - Waterloo CA
  • Liu; Cuixian - Branford CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
[6,6] fused bicyclic HDAC8 inhibitors
Grant 11,414,392 - Zheng , et al. August 16, 2
2022-08-16
Methods Using Hdac11 Inhibitors
App 20220235018 - Lee; Jennifer ;   et al.
2022-07-28
Inhibiting Usp36
App 20220213088 - HAN; Bingsong ;   et al.
2022-07-07
Inhibiting Usp19
App 20220213059 - MARCIN; Lawrence ;   et al.
2022-07-07
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20220204461 - Zheng; Xiaozhang ;   et al.
2022-06-30
Inhibiting Ubiquitin Specific Peptidase 30
App 20220185806 - Caravella; Justin ;   et al.
2022-06-16
Methods using HDAC11 inhibitors
Grant 11,345,672 - Lee , et al. May 31, 2
2022-05-31
Filter Mask
App 20220126130 - Zhang; Ming ;   et al.
2022-04-28
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 11,279,681 - Zheng , et al. March 22, 2
2022-03-22
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 11,274,084 - Zheng , et al. March 15, 2
2022-03-15
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 11,274,085 - Zheng , et al. March 15, 2
2022-03-15
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors
App 20220073452 - Bair; Kenneth W. ;   et al.
2022-03-10
Inhibiting ubiquitin specific peptidase 30
Grant 11,247,987 - Caravella , et al. February 15, 2
2022-02-15
[6,6] Fused Bicyclic Hdac8 Inhibitors
App 20210139439 - Zheng; Xiaozhang ;   et al.
2021-05-13
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
Grant 10,988,441 - Bair , et al. April 27, 2
2021-04-27
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,988,450 - Zheng , et al. April 27, 2
2021-04-27
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20210009539 - Zheng; Xiaozhang ;   et al.
2021-01-14
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20210009540 - Zheng; Xiaozhang ;   et al.
2021-01-14
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20210009538 - Zheng; Xiaozhang ;   et al.
2021-01-14
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,829,461 - Zheng , et al. November 10, 2
2020-11-10
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,829,462 - Zheng , et al. November 10, 2
2020-11-10
[6,6] fused bicyclic HDAC8 inhibitors
Grant 10,829,460 - Zheng , et al. November 10, 2
2020-11-10
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,822,316 - Zheng , et al. November 3, 2
2020-11-03
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors
App 20200331847 - Bair; Kenneth W. ;   et al.
2020-10-22
Inhibiting Ubiquitin Specific Peptidase 30
App 20200317658 - Caravella; Justin ;   et al.
2020-10-08
Methods Using Hdac11 Inhibitors
App 20200079744 - Lee; Jennifer ;   et al.
2020-03-12
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20200055830 - Zheng; Xiaozhang ;   et al.
2020-02-20
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20200048212 - Zheng; Xiaozhang ;   et al.
2020-02-13
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20200048211 - Zheng; Xiaozhang ;   et al.
2020-02-13
Methods using HDAC11 inhibitors
Grant 10,538,496 - Lee , et al. Ja
2020-01-21
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20200002298 - Zheng; Xiaozhang ;   et al.
2020-01-02
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,513,501 - Zheng , et al. Dec
2019-12-24
Methods using HDAC11 inhibitors
Grant 10,508,088 - Lee , et al. Dec
2019-12-17
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
Grant 10,508,077 - Bair , et al. Dec
2019-12-17
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,501,424 - Zheng , et al. Dec
2019-12-10
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,494,352 - Zheng , et al. De
2019-12-03
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,494,353 - Zheng , et al. De
2019-12-03
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,494,354 - Zheng , et al. De
2019-12-03
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,494,351 - Zheng , et al. De
2019-12-03
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,479,772 - Zheng , et al. Nov
2019-11-19
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,472,337 - Zheng , et al. Nov
2019-11-12
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,464,909 - Zheng , et al. No
2019-11-05
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,464,910 - Zheng , et al. No
2019-11-05
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,457,652 - Zheng , et al. Oc
2019-10-29
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,450,283 - Zheng , et al. Oc
2019-10-22
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,450,284 - Zheng , et al. Oc
2019-10-22
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,442,776 - Zheng , et al. Oc
2019-10-15
[6,6] Fused Bicyclic Hdac8 Inhibitors
App 20190308946 - Zheng; Xiaozhang ;   et al.
2019-10-10
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,428,031 - Zheng , et al. October 1, 2
2019-10-01
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,421,732 - Zheng , et al. Sept
2019-09-24
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,421,731 - Zheng , et al. Sept
2019-09-24
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,414,738 - Zheng , et al. Sept
2019-09-17
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,377,726 - Zheng , et al. A
2019-08-13
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors
App 20190241506 - Bair; Kenneth W. ;   et al.
2019-08-08
[6,6] Fused bicyclic HDAC8 inhibitors
Grant 10,370,343 - Zheng , et al.
2019-08-06
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190127339 - Zheng; Xiaozhang ;   et al.
2019-05-02
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119229 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119230 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119231 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119232 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119228 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119227 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119234 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119233 - Zheng; Xiaozhang ;   et al.
2019-04-25
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190119235 - Zheng; Xiaozhang ;   et al.
2019-04-25
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
Grant 10,266,487 - Bair , et al.
2019-04-23
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190112280 - Zheng; Xiaozhang ;   et al.
2019-04-18
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190112281 - Zheng; Xiaozhang ;   et al.
2019-04-18
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190112282 - Zheng; Xiaozhang ;   et al.
2019-04-18
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190112284 - Zheng; Xiaozhang ;   et al.
2019-04-18
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190112279 - Zheng; Xiaozhang ;   et al.
2019-04-18
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190112283 - Zheng; Xiaozhang ;   et al.
2019-04-18
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,239,845 - Zheng , et al.
2019-03-26
Methods Using Hdac11 Inhibitors
App 20190084946 - Lee; Jennifer ;   et al.
2019-03-21
Methods Using Hdac11 Inhibitors
App 20190084945 - Lee; Jennifer ;   et al.
2019-03-21
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190062288 - Zheng; Xiaozhang ;   et al.
2019-02-28
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,214,501 - Zheng , et al. Feb
2019-02-26
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,214,500 - Zheng , et al. Feb
2019-02-26
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190016693 - Zheng; Xiaozhang ;   et al.
2019-01-17
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20190016692 - Zheng; Xiaozhang ;   et al.
2019-01-17
[6,6] Fused Bicyclic Hdac8 Inhibitors
App 20180354919 - Zheng; Xiaozhang ;   et al.
2018-12-13
3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
Grant 10,112,915 - Zheng , et al. October 30, 2
2018-10-30
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors
App 20180297939 - Bair; Kenneth W. ;   et al.
2018-10-18
[6,6] fused bicyclic HDAC8 inhibitors
Grant 10,029,995 - Zheng , et al. July 24, 2
2018-07-24
Methods Using Hdac11 Inhibitors
App 20180127386 - Lee; Jennifer ;   et al.
2018-05-10
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors
App 20180044282 - Bair; Kenneth W. ;   et al.
2018-02-15
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
Grant 9,745,253 - Bair , et al. August 29, 2
2017-08-29
[6,6] Fused Bicyclic Hdac8 Inhibitors
App 20170066729 - Zheng; Xiaozhang ;   et al.
2017-03-09
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors
App 20160264518 - Bair; Kenneth W ;   et al.
2016-09-15
3-aryl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20160221973 - Zheng; Xiaozhang ;   et al.
2016-08-04
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20160221972 - Zheng; Xiaozhang ;   et al.
2016-08-04
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20160222022 - Zheng; Xiaozhang ;   et al.
2016-08-04
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors
App 20160222028 - Zheng; Xiaozhang ;   et al.
2016-08-04
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 9,133,115 - Phadke , et al. September 15, 2
2015-09-15
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20140206604 - Phadke; Avinash ;   et al.
2014-07-24
New 4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20140113890 - Phadke; Avinash ;   et al.
2014-04-24
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
Grant 8,614,180 - Phadke , et al. December 24, 2
2013-12-24
Heteroaryl substituted thiazoles
Grant 8,183,263 - Wang , et al. May 22, 2
2012-05-22
Thiazole Compounds And Methods Of Use
App 20120108576 - Zhang; Suoming ;   et al.
2012-05-03
Thiazole compounds and methods of use
Grant 8,088,806 - Zhang , et al. January 3, 2
2012-01-03
4-amino-4-oxobutanoyl Peptides As Inhibitors Of Viral Replication
App 20100216725 - Phadke; Avinash ;   et al.
2010-08-26
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
Grant 7,767,706 - Phadke , et al. August 3, 2
2010-08-03
4-amino-4-oxobutanoyl Peptide Cyclic Analogues, Inhibitors Of Viral Replication
App 20100152103 - Phadke; Avinash ;   et al.
2010-06-17
Substituted arylthiourea derivatives useful as inhibitors of viral replication
Grant 7,718,671 - Phadke , et al. May 18, 2
2010-05-18
Heteroaryl Substituted Thiazoles
App 20090041720 - Wang; Xiangzhu ;   et al.
2009-02-12
Substituted Aryl Acylthioureas And Related Compounds; Inhibitors Of Viral Replication
App 20090023730 - Phadke; Avinash ;   et al.
2009-01-22
Substituted aryl thioureas and related compounds; inhibitors of viral replication
Grant 7,476,686 - Chen , et al. January 13, 2
2009-01-13
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
Grant 7,365,068 - Phadke , et al. April 29, 2
2008-04-29
Substituted Aminothiazole Derivatives With Anti-HCV Activity
App 20070213301 - Zhang; Souming ;   et al.
2007-09-13
Thiazole compounds and methods of use
App 20070004711 - Zhang; Suoming ;   et al.
2007-01-04
Substituted aryl thioureas and related compounds; inhibitors of viral replication
Grant 7,094,807 - Chen , et al. August 22, 2
2006-08-22
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
App 20060025416 - Phadke; Avinash ;   et al.
2006-02-02
Substituted aryl thioureas and related compounds; inhibitors of viral replication
App 20060014836 - Chen; Dawei ;   et al.
2006-01-19
Substituted arylthiourea derivatives useful as inhibitors of viral replication
App 20050032849 - Phadke, Avinash ;   et al.
2005-02-10
Substituted aryl thioureas and related compounds; inhibitors of viral replication
App 20040138205 - Chen, Dawei ;   et al.
2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed